TITLE

FDA Actions

PUB. DATE
August 2007
SOURCE
Travel Medicine Advisor;Aug2007, Vol. 17 Issue 8, p2
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article reports on the strict regulation of the U.S. Food and Drug Administration (FDA) on its manufacturing practices for dietary supplements. It also states that these supplements are produced in a quality manner, do not contain impurities and are accurately labeled. Pregabalin from Lyrica-Pfizer has been the first drug to be approved for fibromyalgia, partial seizures and diabetic neuropathy.
ACCESSION #
26267120

 

Related Articles

  • FDA Actions.  // OB/GYN Clinical Alert;Aug2007, Vol. 24 Issue 4, p2 

    The article presents an update on the U.S. Food and Drug Administration (FDA) as of August 2007. The agency has issued a final rule that requires current good manufacturing practices for dietary supplements. The drug Pregabalin manufactured by Pfizer has been approved for the treatment of...

  • FDA Actions. Elliott, William T. // Clinical Oncology Alert;Aug2007 Pharmacology Watch, p2 

    The article reveals that the U.S. Food & Drug Administration has strengthened its regulations regarding dietary supplements. The agency issued a final rule requiring current good manufacturing practices for dietary supplements. Meanwhile, Pregabalin has been approved for the treatment of...

  • FDA Actions.  // Infectious Disease Alert;Aug2007, Vol. 26 Issue 11, p2 

    The article focuses on issues related to the pharmaceutical industry in the U.S. The Food and Drug Administration has issued a final rule requiring good manufacturing practices for dietary supplements. It mentions that pregabalin has been approved for the treatment of fibromyalgia, which is...

  • FDA Actions.  // Primary Care Reports;Aug2007, Vol. 13 Issue 8, p2 

    The article reports on the issuance of a final rule by the U.S. Food and Drug Administration (FDA) requiring current good manufacturing practices for dietary supplements. The rule also requires manufacturers to report all serious dietary supplement-related adverse events to the FDA by the end of...

  • Pregabalin: An antiepileptic agent useful for neuropathic pain. BLOMMEL, MATTHEW L.; BLOMMEL, AMY L. // American Journal of Health-System Pharmacy;7/15/2007, Vol. 64 Issue 14, p1475 

    Purpose. The pharmacology, pharmacokinetics, clinical efficacy, adverse effects, and dosage and administration of pregabalin are reviewed. Summary. Pregabalin is the first drug to receive approved labeling from the Food and Drug Administration (FDA) for the treatment of painful diabetic...

  • Vitamins: Fact or fiction?  // Restaurant Business;8/10/93, Vol. 92 Issue 12, p132 

    Reports on the Food and Drug Administration (FDA) proposal to crackdown on the dietary supplement industry. Reaction by dietary supplement manufacturers and users; Evaluation of products with questionable nutritional value; Chaparral; L-tryptophan; Guar gum; Germanium.

  • "The Sky is Falling, the Sky is Falling" (maybe some of it is). Czap, Al // Alternative Medicine Review;Sep2011, Vol. 16 Issue 3, p209 

    The author comments on the guidelines issued by the U.S. Food and Drug Administration (FDA) concerning the release and marketing of new dietary ingredients (NDI) on July 2, 2011. He says that the guidelines emphasize that the essential proof to identify that an ingredient was marketed in the...

  • DMAA Causes More NDI Issues.  // Nutraceuticals World;Jun2012, Vol. 15 Issue 5, p18 

    The article reports on the move of the U.S. Food and Drug Administration (FDA) in issuing warning letters to marketers of ,3-dimethylamylamine (DMAA)-containing dietary supplements.

  • Supplements: What the FDA doesn't tell you. Block, Gladys // Consumers' Research Magazine;Feb94, Vol. 77 Issue 2, p19 

    Part II. Looks at statistics of the vitamin intake of Americans. The fraction of Americans who take a dietary supplement daily; Comparisons with vitamin intake in 1987; Concerns of the Food and Drug Administration (FDA) regarding the use of vitamins; The issue of toxicity; Public policy and...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics